BR9808720A - Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães - Google Patents

Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães

Info

Publication number
BR9808720A
BR9808720A BR9808720-7A BR9808720A BR9808720A BR 9808720 A BR9808720 A BR 9808720A BR 9808720 A BR9808720 A BR 9808720A BR 9808720 A BR9808720 A BR 9808720A
Authority
BR
Brazil
Prior art keywords
cox
activity
dogs
acids
carprofen
Prior art date
Application number
BR9808720-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9808720A publication Critical patent/BR9808720A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR9808720-7A 1997-05-05 1998-05-01 Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães BR9808720A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
BR9808720A true BR9808720A (pt) 2000-07-11

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808720-7A BR9808720A (pt) 1997-05-05 1998-05-01 Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães

Country Status (32)

Country Link
EP (1) EP0988034A1 (es)
JP (1) JP2000513020A (es)
KR (2) KR20010012300A (es)
CN (1) CN1255059A (es)
AP (1) AP9801234A0 (es)
AR (2) AR011726A1 (es)
AU (1) AU6932198A (es)
BG (1) BG103852A (es)
BR (1) BR9808720A (es)
CA (1) CA2288759A1 (es)
DZ (1) DZ2479A1 (es)
EA (1) EA003696B1 (es)
GT (1) GT199800063A (es)
HR (1) HRP980244A2 (es)
HU (1) HUP0001286A3 (es)
ID (1) ID21311A (es)
IL (1) IL132570A0 (es)
IS (1) IS5220A (es)
MA (1) MA26491A1 (es)
NO (1) NO995389L (es)
NZ (1) NZ500183A (es)
OA (1) OA11213A (es)
PA (1) PA8450601A1 (es)
PE (1) PE72599A1 (es)
PL (1) PL337003A1 (es)
SK (1) SK148199A3 (es)
TN (1) TNSN98059A1 (es)
TW (1) TW590773B (es)
UY (1) UY24989A1 (es)
WO (1) WO1998050033A1 (es)
YU (1) YU55899A (es)
ZA (1) ZA983722B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1158977B1 (en) * 1999-03-10 2005-10-12 G.D. Searle LLC Composition for administering a cyclooxygenase-2 inhibitor to animals
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
HU229440B1 (en) 2000-06-13 2013-12-30 Wyeth Corp Analgesic and anti-inflammatory compositions containing gox-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
EP1307585B1 (en) 2000-08-07 2009-01-21 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
EP2266585B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
MXPA06001288A (es) * 2003-07-31 2006-04-11 Upjohn Co Formulacion dispersable de un agente anti-inflamatorio.
EP1940380A2 (en) * 2005-05-20 2008-07-09 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands
JP2010523555A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド 「経口医薬組成物」
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
SG176145A1 (en) 2009-05-18 2011-12-29 Sigmoid Pharma Ltd Composition comprising oil drops
JP5911799B2 (ja) 2009-08-12 2016-04-27 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ ポリマーマトリックスおよび油相を含んで成る免疫調節組成物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
PL3113774T3 (pl) * 2014-03-06 2022-06-13 Elanco Animal Health Incorporated Kompozycje grapiprantu i sposoby ich zastosowania
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
KR20170103834A (ko) * 2015-01-09 2017-09-13 재규어 애니멀 헬스 반려 동물의 설사 치료 방법
WO2021195346A1 (en) * 2020-03-25 2021-09-30 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
OA11213A (en) 2003-07-14
CN1255059A (zh) 2000-05-31
ZA983722B (en) 1999-11-04
HUP0001286A2 (hu) 2000-11-28
AR011726A1 (es) 2000-08-30
YU55899A (sh) 2003-08-29
AU6932198A (en) 1998-11-27
KR20010012300A (ko) 2001-02-15
EA199900895A1 (ru) 2000-06-26
PL337003A1 (en) 2000-07-31
GT199800063A (es) 1999-10-26
KR20040004406A (ko) 2004-01-13
AR039628A2 (es) 2005-03-02
PA8450601A1 (es) 2000-05-24
HRP980244A2 (en) 1999-02-28
DZ2479A1 (fr) 2003-02-01
PE72599A1 (es) 1999-08-12
EA003696B1 (ru) 2003-08-28
HUP0001286A3 (en) 2000-12-28
TW590773B (en) 2004-06-11
AP9801234A0 (en) 1999-11-04
WO1998050033A1 (en) 1998-11-12
CA2288759A1 (en) 1998-11-12
NZ500183A (en) 2002-04-26
NO995389L (no) 2000-01-04
IS5220A (is) 1999-10-19
ID21311A (id) 1999-05-20
BG103852A (en) 2000-06-30
UY24989A1 (es) 2001-10-25
JP2000513020A (ja) 2000-10-03
MA26491A1 (fr) 2004-12-20
IL132570A0 (en) 2001-03-19
SK148199A3 (en) 2001-09-11
EP0988034A1 (en) 2000-03-29
TNSN98059A1 (fr) 2005-03-15
NO995389D0 (no) 1999-11-04

Similar Documents

Publication Publication Date Title
BR9808720A (pt) Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães
Kolbe et al. 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation
DE1073432T1 (de) Verwendung von glycinrezeptoragonisten und glycinaufnahmeinhibitoren zur behandlung neuropsychiatrischer beschwerden
CY1107729T1 (el) Φαρμακευτικες συνθεσεις
ATE527022T1 (de) Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
EA200200246A1 (ru) Композиция, содержащая нестероидное противовоспалительное средство (nsaid) и ингибитор киназы egfr, для лечения или ингибирования полипов в ободочной кишке и рака ободочной и прямой кишки
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
BR9814147A (pt) "derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf"
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
PT815087E (pt) Derivados de fenilo trissubstituidos
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
Ventura-Martínez et al. Peripheral involvement of the nitric oxide–cGMP pathway in the indomethacin-induced antinociception in rat
Jain et al. Analgesic, anti‐inflammatory and ulcerogenic activity of a zinc‐naproxen complex in mice and rats
DK1154766T3 (da) Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B
ATE345123T1 (de) Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten
HUP0400886A2 (hu) Koleszteril-észter transzfer protein inhibitorok és fibrinsav-származékok kombinációi szív-érrendszeri indikációkhoz
HUP0300689A2 (hu) Eljárás és kompozíciók gyulladásos betegségek kezelésére
Belichard et al. Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide‐treated rats
WO2002096870A3 (en) Sponge-derived terpenoids and methods of use
ATE374197T1 (de) Indolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE516038T1 (de) Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007.